← Back to Clinical Trials
Recruiting NCT07482995

NCT07482995 Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07482995
Status Recruiting
Phase —
Sponsor China-Japan Friendship Hospital
Condition Sedentary Lifestyle
Study Type INTERVENTIONAL
Enrollment 208 participants
Start Date 2026-09-30
Primary Completion 2027-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 59 Years
Study Type INTERVENTIONAL
Interventions
Baduanjin exerciseGeneral Health Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 208 participants in total. It began in 2026-09-30 with a primary completion date of 2027-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are: 1. Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)? 2. Does it improve their body composition, muscle strength, balance, and flexibility? 3. Does it reduce their daily sitting time? Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes. Participants will: 1. Be randomly assigned to one of the two groups. 2. If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks. 3. Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 to 59 years * Sedentary and physically inactive, defined as: (a) self-reported sitting time ≥ 8 hours per day, AND (b) not meeting the World Health Organization (WHO) recommended level of physical activity ( engaging in \< 150 minutes of moderate-to-vigorous intensity physical activity per week, assessed by the International Physical Activity Questionnaire \[IPAQ\]) * In good general health as self-reported, and free from any known diseases * Willing and able to provide written informed consent Exclusion Criteria: * Contraindications to cardiopulmonary exercise testing * Currently participating in, or planning to participate within the next 3 months, in any other structured exercise or behavioral intervention program * Pregnancy, lactation, or planning to become pregnant during the study period * Inability to understand or comply with the study procedures

Contact & Investigator

Central Contact

Jingyi Ren, M.D., Chief Physician

✉ renjingyi@cjfh.org.cn

📞 18600195099

Frequently Asked Questions

Who can join the NCT07482995 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Sedentary Lifestyle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07482995 currently recruiting?

Yes, NCT07482995 is actively recruiting participants. Contact the research team at renjingyi@cjfh.org.cn for enrollment information.

Where is the NCT07482995 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT07482995 clinical trial?

NCT07482995 is sponsored by China-Japan Friendship Hospital. The trial plans to enroll 208 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology